Literature DB >> 9400935

Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia.

S P Dobbs1, P W Hewett, I R Johnson, J Carmichael, J C Murray.   

Abstract

Squamous cell carcinoma of the cervix (SCC) is preceded by a premalignant condition known as cervical intraepithelial neoplasia (CIN). The majority of cases of CIN regress spontaneously; however, methods are needed to identify those lesions likely to progress. Increased blood vessel density, signifying angiogenesis, is an independent prognostic indicator in a number of cancers, although little is known about its significance in premalignant lesions. The aim of the present study was to determine the relationship between vessel density, expression of the potent angiogenic factor vascular endothelial growth factor (VEGF) and CIN grade. Using immunohistochemistry, mean vessel density (MVD) and VEGF expression were assessed in samples from 54 patients who had undergone cone biopsy for CIN or hysterectomy for SCC and from 16 patients with no cervical pathology. There were significant increases in MVD and VEGF expression from normal cervix through CIN I to CIN III to invasive SCC, but no difference in mean vessel diameter between groups. There was a strong correlation between mean vessel density and VEGF expression, and both were associated with histological grade of CIN. The original MVDs for a small group of patients later presenting with recurrent disease were found to be equal to or greater than the mean for their histological grade. We conclude that the onset of angiogenesis is an early event in premalignant changes of the cervix due, in part, to enhanced expression of VEGF by the abnormal epithelium.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9400935      PMCID: PMC2228179          DOI: 10.1038/bjc.1997.571

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  40 in total

1.  Angiogenesis of cervical neoplasia.

Authors:  A Stafl; R F Mattingly
Journal:  Am J Obstet Gynecol       Date:  1975-03-15       Impact factor: 8.661

2.  Vascularization and radiocurability in cancer of the uterine cervix. A retrospective study.

Authors:  E Siracká; J Siracký; N Pappová; L Révész
Journal:  Neoplasma       Date:  1982       Impact factor: 2.575

3.  The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study.

Authors:  A Srivastava; P Laidler; R P Davies; K Horgan; L E Hughes
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

4.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.

Authors:  N Weidner; J Folkman; F Pozza; P Bevilacqua; E N Allred; D H Moore; S Meli; G Gasparini
Journal:  J Natl Cancer Inst       Date:  1992-12-16       Impact factor: 13.506

5.  The invasive potential of carcinoma in situ of the cervix.

Authors:  W A McIndoe; M R McLean; R W Jones; P R Mullins
Journal:  Obstet Gynecol       Date:  1984-10       Impact factor: 7.661

6.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.

Authors:  E R Horak; R Leek; N Klenk; S LeJeune; K Smith; N Stuart; M Greenall; K Stepniewska; A L Harris
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

7.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

Authors:  K H Plate; G Breier; H A Weich; W Risau
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

8.  Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer.

Authors:  L F Brown; B Berse; R W Jackman; K Tognazzi; A J Guidi; H F Dvorak; D R Senger; J L Connolly; S J Schnitt
Journal:  Hum Pathol       Date:  1995-01       Impact factor: 3.466

9.  Risk of cervical cancer associated with mild dyskaryosis.

Authors:  J H Robertson; B E Woodend; E H Crozier; J Hutchinson
Journal:  BMJ       Date:  1988-07-02

10.  Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation.

Authors:  G Breier; U Albrecht; S Sterrer; W Risau
Journal:  Development       Date:  1992-02       Impact factor: 6.868

View more
  26 in total

1.  Intraepithelially entrapped blood vessels in oral carcinoma in-situ.

Authors:  Akinori Funayama; Satoshi Maruyama; Manabu Yamazaki; Kamal Al-Eryani; Susumu Shingaki; Chikara Saito; Jun Cheng; Takashi Saku
Journal:  Virchows Arch       Date:  2012-04-05       Impact factor: 4.064

2.  Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.

Authors:  M Branca; C Giorgi; D Santini; L Di Bonito; M Ciotti; A Benedetto; P Paba; S Costa; D Bonifacio; P Di Bonito; L Accardi; C Favalli; K Syrjänen
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

Review 3.  Angiogenesis in prolactinomas: regulation and relationship with tumour behaviour.

Authors:  N Garcia de la Torre; H E Turner; J A H Wass
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

4.  Thymidine phosphorylase expression in progression of cervical cancer: correlation with microvessel count, proliferating cell nuclear antigen, and apoptosis.

Authors:  R Fujiwaki; K Hata; K Iida; Y Maede; M Koike; K Miyazaki
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

5.  Hemoglobin parameters from diffuse reflectance data.

Authors:  Judith R Mourant; Oana C Marina; Tiffany M Hebert; Gurpreet Kaur; Harriet O Smith
Journal:  J Biomed Opt       Date:  2014-03       Impact factor: 3.170

Review 6.  Angiogenesis in epithelian ovarian cancer.

Authors:  E S Bamberger; C W Perrett
Journal:  Mol Pathol       Date:  2002-12

7.  A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study.

Authors:  John K Chan; Wei Deng; Robert V Higgins; Krishnansu S Tewari; Albert J Bonebrake; Michael Hicks; Stephanie Gaillard; Pedro T Ramirez; Weldon Chafe; Bradley J Monk; Carol Aghajanian
Journal:  Gynecol Oncol       Date:  2017-07-18       Impact factor: 5.482

8.  Serum vascular endothelial growth factor: a prognostic factor in cervical cancer.

Authors:  Petra L M Zusterzeel; Paul N Span; Marja G K Dijksterhuis; Chris M G Thomas; Fred C G J Sweep; Leon F A G Massuger
Journal:  J Cancer Res Clin Oncol       Date:  2008-07-15       Impact factor: 4.553

9.  An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

Authors:  Enrico Giraudo; Masahiro Inoue; Douglas Hanahan
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

10.  UFT and its metabolite gamma-butyrolactone (GBL) inhibit angiogenesis induced by vascular endothelial growth factor in advanced cervical carcinoma.

Authors:  Nobutaka Nagai; Keiji Mukai; Eiji Hirata; Hong Hua Jin; Masaaki Komatsu; Mayu Yunokawa
Journal:  Med Oncol       Date:  2007-10-30       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.